Ind-Swift Laboratories Limited (INDSWFTLAB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ind-Swift Laboratories Limited (INDSWFTLAB) has a cash flow conversion efficiency ratio of -0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-202.50 Million ≈ $-2.19 Million USD) by net assets (Rs13.07 Billion ≈ $141.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Ind-Swift Laboratories Limited for the company's overall valuation and market capitalisation.
Ind-Swift Laboratories Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Ind-Swift Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ind-Swift Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ind-Swift Laboratories Limited ranked by their cash flow conversion efficiency. Explore Ind-Swift Laboratories Limited (INDSWFTLAB) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong Anjubao Digital Tech
SHE:300155
|
0.000x |
|
LPKF Laser & Electronics AG
F:LPK
|
-0.091x |
|
M-tron Industries, Inc.
NYSE MKT:MPTI
|
0.042x |
|
Southern Score Builders Berhad
KLSE:0045
|
0.004x |
|
Mobia Medical, Inc. Common Stock
NASDAQ:MOBI
|
0.106x |
|
Jiangsu Chunlan Refrigerating Equipment Stock Co Ltd
SHG:600854
|
0.006x |
|
Sichuan Tianwei Electronic Co Ltd
SHG:688511
|
-0.013x |
|
Poongsan Holdi
KO:005810
|
0.011x |
Annual Cash Flow Conversion Efficiency for Ind-Swift Laboratories Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. View Ind-Swift Laboratories Limited share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs11.73 Billion ≈ $126.85 Million |
Rs-254.74 Million ≈ $-2.75 Million |
-0.022x | +89.19% |
| 2024-03-31 | Rs8.12 Billion ≈ $87.82 Million |
Rs-1.63 Billion ≈ $-17.64 Million |
-0.201x | -170.38% |
| 2023-03-31 | Rs6.82 Billion ≈ $73.75 Million |
Rs1.95 Billion ≈ $21.05 Million |
0.285x | +14.11% |
| 2022-03-31 | Rs6.01 Billion ≈ $64.98 Million |
Rs1.50 Billion ≈ $16.25 Million |
0.250x | +11.83% |
| 2021-03-31 | Rs6.03 Billion ≈ $65.26 Million |
Rs1.35 Billion ≈ $14.59 Million |
0.224x | +14.40% |
| 2020-03-31 | Rs6.41 Billion ≈ $69.28 Million |
Rs1.25 Billion ≈ $13.54 Million |
0.195x | +278.44% |
| 2019-03-31 | Rs5.88 Billion ≈ $63.57 Million |
Rs-644.00 Million ≈ $-6.96 Million |
-0.110x | -182.93% |
| 2018-03-31 | Rs5.53 Billion ≈ $59.83 Million |
Rs730.90 Million ≈ $7.90 Million |
0.132x | -26.55% |
| 2017-03-31 | Rs5.31 Billion ≈ $57.46 Million |
Rs955.66 Million ≈ $10.34 Million |
0.180x | +17.17% |
| 2016-03-31 | Rs5.17 Billion ≈ $55.96 Million |
Rs794.30 Million ≈ $8.59 Million |
0.154x | -7.25% |
| 2015-03-31 | Rs5.95 Billion ≈ $64.30 Million |
Rs983.98 Million ≈ $10.64 Million |
0.166x | +83.17% |
| 2014-03-31 | Rs7.25 Billion ≈ $78.43 Million |
Rs655.29 Million ≈ $7.09 Million |
0.090x | +265.47% |
| 2013-03-31 | Rs8.53 Billion ≈ $92.30 Million |
Rs-466.03 Million ≈ $-5.04 Million |
-0.055x | -161.11% |
| 2012-03-31 | Rs8.12 Billion ≈ $87.78 Million |
Rs725.24 Million ≈ $7.84 Million |
0.089x | +193.19% |
| 2011-03-31 | Rs5.84 Billion ≈ $63.10 Million |
Rs177.83 Million ≈ $1.92 Million |
0.030x | -69.08% |
| 2010-03-31 | Rs4.48 Billion ≈ $48.48 Million |
Rs441.84 Million ≈ $4.78 Million |
0.099x | -64.25% |
| 2009-03-31 | Rs3.63 Billion ≈ $39.27 Million |
Rs1.00 Billion ≈ $10.83 Million |
0.276x | +61.91% |
| 2008-03-31 | Rs3.33 Billion ≈ $36.06 Million |
Rs567.77 Million ≈ $6.14 Million |
0.170x | +17.18% |
| 2007-03-31 | Rs3.11 Billion ≈ $33.68 Million |
Rs452.62 Million ≈ $4.89 Million |
0.145x | +137.58% |
| 2006-03-31 | Rs1.92 Billion ≈ $20.80 Million |
Rs117.63 Million ≈ $1.27 Million |
0.061x | -- |
About Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hy… Read more